Symbols / SRTS Stock $4.23 +0.00% Sensus Healthcare, Inc.

Healthcare • Medical Devices • United States • NCM
SRTS (Stock) Chart
About

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 69.63M
Enterprise Value 46.05M Income -7.72M Sales 27.48M
Book/sh 1.57 Cash/sh 1.34 Dividend Yield —
Payout 0.00% Employees 60 IPO —
P/E — Forward P/E 66.79 PEG —
P/S 2.53 P/B 2.70 P/C —
EV/EBITDA -4.64 EV/Sales 1.68 Quick Ratio 5.96
Current Ratio 9.72 Debt/Eq 0.98 LT Debt/Eq —
EPS (ttm) -0.47 EPS next Y 0.06 EPS Growth —
Revenue Growth -62.20% Earnings 2026-05-14 ROA -11.18%
ROE -14.85% ROIC — Gross Margin 43.18%
Oper. Margin -63.74% Profit Margin -28.09% Shs Outstand 16.46M
Shs Float 13.55M Short Float 2.63% Short Ratio 3.72
Short Interest — 52W High 5.92 52W Low 3.03
Beta 1.28 Avg Volume 90.63K Volume 803.00
Target Price $6.88 Recom None Prev Close $4.23
Price $4.23 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.88
Mean price target
2. Current target
$4.34
Latest analyst target
3. DCF / Fair value
$4.30
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.34
Low
$6.00
High
$8.00
Mean
$6.88

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-17 main Maxim Group Buy → Buy $6
2025-08-12 main HC Wainwright & Co. Buy → Buy $8
2025-08-08 main Lake Street Buy → Buy $6
2025-05-19 main Maxim Group Buy → Buy $10
2025-04-04 reit HC Wainwright & Co. Buy → Buy $12
2025-03-11 main Lake Street Buy → Buy $13
2025-02-10 main HC Wainwright & Co. Buy → Buy $12
2024-11-18 main HC Wainwright & Co. Buy → Buy $11
2024-11-15 main Maxim Group Buy → Buy $14
2024-08-12 reit HC Wainwright & Co. Buy → Buy $10
2024-05-13 main HC Wainwright & Co. Buy → Buy $10
2024-05-10 main Maxim Group Buy → Buy $10
2023-11-13 reit HC Wainwright & Co. Buy → Buy $8
2023-08-07 main HC Wainwright & Co. Buy → Buy $8
2023-05-04 reit HC Wainwright & Co. — → Buy $10
2023-05-04 main Alliance Global Partners — → Buy $7
2023-02-10 reit HC Wainwright & Co. — → Buy $16
2023-02-10 main Alliance Global Partners — → Buy $15
2022-11-04 main Alliance Global Partners — → Buy $17
2022-05-06 main HC Wainwright & Co. — → Buy $16
News
RSS: Latest SRTS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-24 SACHETTA ERIC Director — 2,000 $3.81 $7,620
2025-12-12 SARDANO MICHAEL President — 40,000 $0.00 $0
2025-11-21 SACHETTA ERIC Director — 7,000 $3.93 $27,510
2025-11-18 SARDANO JOSEPH C Chief Executive Officer — 25,000 $4.03 $100,750
2025-11-18 SARDANO MICHAEL President — 1,000 $3.80 $3,800
2025-11-13 SACHETTA ERIC Director — 2,500 $4.50 $11,250
2025-11-11 SARDANO MICHAEL President — 1,000 $4.26 $4,260
2025-11-11 SARDANO MICHAEL President — 2,000 $4.24 $8,523
2025-11-11 SARDANO MICHAEL President — 2,000 $4.26 $8,546
2025-08-13 SARDANO MICHAEL President — 1,000 $3.37 $3,370
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
27.48
-34.26%
41.81
+71.31%
24.41
-45.20%
44.53
Operating Revenue
27.48
-34.26%
41.81
+71.31%
24.41
-45.20%
44.53
Cost Of Revenue
15.62
-10.13%
17.38
+67.97%
10.35
-30.59%
14.90
Reconciled Cost Of Revenue
15.62
-10.13%
17.38
+67.97%
10.35
-30.59%
14.90
Gross Profit
11.87
-51.43%
24.43
+73.76%
14.06
-52.54%
29.63
Operating Expense
22.17
+35.70%
16.34
+13.15%
14.44
-2.40%
14.80
Research And Development
7.78
+84.49%
4.22
+14.63%
3.68
+6.30%
3.46
Selling General And Administration
14.40
+18.73%
12.12
+12.64%
10.76
-5.05%
11.34
Selling And Marketing Expense
6.52
+31.04%
4.98
-11.23%
5.61
-11.39%
6.33
General And Administrative Expense
7.87
+10.16%
7.15
+38.62%
5.16
+2.96%
5.01
Other Gand A
7.87
+10.16%
7.15
+38.62%
5.16
+2.96%
5.01
Total Expenses
37.79
+12.08%
33.72
+36.03%
24.79
-16.54%
29.70
Operating Income
-10.31
-227.40%
8.09
+2217.80%
-0.38
-102.58%
14.83
Total Operating Income As Reported
-10.31
-227.40%
8.09
+2217.80%
-0.38
-102.58%
14.83
EBITDA
-9.68
-213.60%
8.52
+10687.34%
0.08
-99.49%
15.34
Normalized EBITDA
-9.68
-213.60%
8.52
+22932.43%
0.04
-98.56%
2.56
Reconciled Depreciation
0.63
+44.91%
0.43
-6.29%
0.46
-9.43%
0.51
EBIT
-10.31
-227.40%
8.09
+2217.80%
-0.38
-102.58%
14.83
Total Unusual Items
—
0.00
-100.00%
0.04
-99.67%
12.78
Total Unusual Items Excluding Goodwill
—
0.00
-100.00%
0.04
-99.67%
12.78
Special Income Charges
—
0.00
-100.00%
0.04
-99.67%
12.78
Restructuring And Mergern Acquisition
—
—
—
—
Net Income
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Pretax Income
-9.62
-206.67%
9.02
+1283.74%
0.65
-97.67%
27.99
Net Non Operating Interest Income Expense
0.68
-26.72%
0.93
-6.05%
0.99
+161.05%
0.38
Interest Expense Non Operating
—
—
—
0.00
Net Interest Income
0.68
-26.72%
0.93
-6.05%
0.99
+161.05%
0.38
Interest Expense
—
—
—
0.00
Interest Income Non Operating
0.68
-26.72%
0.93
-6.05%
0.99
+161.05%
0.38
Interest Income
0.68
-26.72%
0.93
-6.05%
0.99
+161.05%
0.38
Other Income Expense
—
—
0.04
-99.67%
12.78
Tax Provision
-1.91
-180.21%
2.38
+1322.16%
0.17
-95.54%
3.75
Tax Rate For Calcs
0.00
-24.05%
0.00
+2.34%
0.00
+91.04%
0.00
Tax Effect Of Unusual Items
0.00
0.00
-100.00%
0.01
-99.37%
1.71
Net Income Including Noncontrolling Interests
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Net Income From Continuing Operation Net Minority Interest
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Net Income From Continuing And Discontinued Operation
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Net Income Continuous Operations
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Normalized Income
-7.72
-216.13%
6.65
+1364.90%
0.45
-96.56%
13.18
Net Income Common Stockholders
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Diluted EPS
-0.47
-214.63%
0.41
+1266.67%
0.03
-97.95%
1.46
Basic EPS
-0.47
-214.63%
0.41
+1266.67%
0.03
-97.96%
1.47
Basic Average Shares
16.33
+0.09%
16.31
+0.33%
16.26
-1.35%
16.48
Diluted Average Shares
16.33
-0.20%
16.36
+0.57%
16.27
-2.12%
16.62
Diluted NI Availto Com Stockholders
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Gain On Sale Of PPE
—
0.00
-100.00%
0.04
-99.67%
12.78
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
53.04
-14.68%
62.16
+15.74%
53.71
-5.33%
56.73
Current Assets
45.89
-19.12%
56.74
+14.56%
49.53
-6.97%
53.24
Cash Cash Equivalents And Short Term Investments
22.08
+0.12%
22.06
-4.72%
23.15
-9.29%
25.52
Cash And Cash Equivalents
22.08
+0.12%
22.06
-4.72%
23.15
-9.29%
25.52
Receivables
6.04
-69.38%
19.73
+85.35%
10.64
-38.46%
17.30
Accounts Receivable
6.04
-69.38%
19.73
+85.35%
10.64
-38.46%
17.30
Gross Accounts Receivable
6.14
-69.03%
19.83
+86.29%
10.64
-38.84%
17.41
Allowance For Doubtful Accounts Receivable
-0.10
+0.00%
-0.10
0.00
+100.00%
-0.11
Inventory
14.56
+44.23%
10.10
-14.87%
11.86
+238.79%
3.50
Finished Goods
—
—
—
3.50
Prepaid Assets
1.52
-54.53%
3.35
+12.09%
2.99
-52.31%
6.26
Other Current Assets
1.68
+11.68%
1.51
+69.71%
0.89
+34.55%
0.66
Total Non Current Assets
7.15
+31.69%
5.43
+29.77%
4.18
+19.69%
3.49
Net PPE
2.43
-5.82%
2.58
+108.24%
1.24
-0.08%
1.24
Gross PPE
4.87
+3.66%
4.70
+50.53%
3.12
-7.39%
3.37
Accumulated Depreciation
-2.44
-15.19%
-2.12
-12.59%
-1.88
+11.64%
-2.13
Machinery Furniture Equipment
0.19
+10.71%
0.17
+15.86%
0.14
-10.49%
0.16
Construction In Progress
0.47
+107.89%
0.23
0.00
—
Other Properties
4.21
-2.14%
4.30
+44.56%
2.98
-7.23%
3.21
Goodwill And Other Intangible Assets
—
—
—
0.05
Other Intangible Assets
—
—
—
0.05
Non Current Deferred Assets
4.08
+85.66%
2.20
+2.66%
2.14
+24.93%
1.71
Non Current Deferred Taxes Assets
4.08
+85.66%
2.20
+2.66%
2.14
+24.93%
1.71
Non Current Prepaid Assets
—
—
—
0.02
Other Non Current Assets
0.64
-1.84%
0.65
-18.91%
0.80
+48.34%
0.54
Total Liabilities Net Minority Interest
4.94
-22.04%
6.34
+30.20%
4.87
-43.83%
8.67
Current Liabilities
4.72
-19.76%
5.88
+39.72%
4.21
-45.28%
7.70
Payables And Accrued Expenses
3.34
-30.51%
4.81
+70.00%
2.83
-55.86%
6.41
Payables
3.34
-30.51%
4.81
+70.00%
2.83
-55.86%
6.41
Accounts Payable
3.34
-30.51%
4.81
+72.25%
2.79
-49.41%
5.52
Total Tax Payable
—
0.00
-100.00%
0.04
-95.84%
0.89
Income Tax Payable
—
0.00
-100.00%
0.04
-95.84%
0.89
Current Debt And Capital Lease Obligation
0.26
+28.43%
0.20
+9.09%
0.19
-1.58%
0.19
Current Debt
—
—
—
—
Other Current Borrowings
—
—
—
—
Current Capital Lease Obligation
0.26
+28.43%
0.20
+9.09%
0.19
-1.58%
0.19
Current Deferred Liabilities
0.84
+55.64%
0.54
-17.66%
0.66
-5.19%
0.69
Current Deferred Revenue
0.84
+55.64%
0.54
-17.66%
0.66
-5.19%
0.69
Other Current Liabilities
—
—
—
0.40
Total Non Current Liabilities Net Minority Interest
0.22
-51.66%
0.45
-30.95%
0.66
-32.30%
0.97
Long Term Debt And Capital Lease Obligation
0.21
-47.49%
0.40
-33.22%
0.60
-28.19%
0.83
Long Term Capital Lease Obligation
0.21
-47.49%
0.40
-33.22%
0.60
-28.19%
0.83
Non Current Deferred Liabilities
0.01
-81.82%
0.06
-8.33%
0.06
-56.83%
0.14
Non Current Deferred Revenue
0.01
-81.82%
0.06
-8.33%
0.06
-56.83%
0.14
Stockholders Equity
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Common Stock Equity
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Capital Stock
0.17
+0.00%
0.17
+0.00%
0.17
+0.00%
0.17
Common Stock
0.17
+0.00%
0.17
+0.00%
0.17
+0.00%
0.17
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
17.06
+0.12%
17.04
+0.77%
16.91
+0.03%
16.90
Ordinary Shares Number
16.46
-0.19%
16.50
+0.74%
16.37
-0.10%
16.39
Treasury Shares Number
0.59
+9.53%
0.54
+1.60%
0.53
+4.02%
0.51
Additional Paid In Capital
46.09
+0.64%
45.80
+0.86%
45.41
+0.83%
45.03
Retained Earnings
5.71
-57.46%
13.43
+97.94%
6.79
+7.70%
6.30
Treasury Stock
3.88
+8.54%
3.57
+1.48%
3.52
+2.51%
3.43
Total Equity Gross Minority Interest
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Total Capitalization
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Working Capital
41.17
-19.04%
50.85
+12.22%
45.32
-0.50%
45.54
Invested Capital
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Total Debt
0.47
-21.76%
0.60
-23.12%
0.78
-23.24%
1.02
Capital Lease Obligations
0.47
-21.76%
0.60
-23.12%
0.78
-23.24%
1.02
Net Tangible Assets
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Tangible Book Value
48.10
-13.84%
55.83
+14.30%
48.84
+1.61%
48.07
Current Provisions
0.28
-16.41%
0.33
-38.85%
0.54
+33.50%
0.40
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
0.53
+163.54%
-0.83
+61.26%
-2.15
-51.91%
-1.41
Cash Flow From Continuing Operating Activities
0.53
+163.54%
-0.83
+61.26%
-2.15
-51.91%
-1.41
Net Income From Continuing Operations
-7.72
-216.13%
6.65
+1270.52%
0.48
-98.00%
24.24
Depreciation Amortization Depletion
0.63
+44.91%
0.43
-6.29%
0.46
-9.43%
0.51
Depreciation
0.63
+44.91%
0.43
-6.29%
0.46
-9.43%
0.51
Amortization Cash Flow
—
—
—
0.10
Depreciation And Amortization
0.63
+44.91%
0.43
-6.29%
0.46
-9.43%
0.51
Amortization Of Intangibles
—
—
—
0.10
Other Non Cash Items
—
—
—
—
Stock Based Compensation
0.29
-8.67%
0.32
-1.52%
0.33
+75.40%
0.19
Provisionand Write Offof Assets
0.55
+44.71%
0.38
-37.31%
0.60
-16.48%
0.72
Asset Impairment Charge
—
0.12
+1657.14%
0.01
-95.17%
0.14
Deferred Tax
-1.88
-3201.75%
-0.06
+86.65%
-0.43
+75.07%
-1.71
Deferred Income Tax
-1.88
-3201.75%
-0.06
+86.65%
-0.43
+75.07%
-1.71
Operating Gains Losses
—
—
-0.04
+99.67%
-12.58
Gain Loss On Sale Of PPE
—
—
—
0.00
Change In Working Capital
8.66
+201.25%
-8.55
-140.28%
-3.56
+72.45%
-12.92
Change In Receivables
13.65
+248.18%
-9.21
-238.54%
6.65
+225.08%
-5.31
Changes In Account Receivables
13.65
+248.18%
-9.21
-238.54%
6.65
+225.08%
-5.31
Change In Inventory
-4.63
-1829.48%
0.27
+103.12%
-8.58
-168.79%
-3.19
Change In Prepaid Assets
1.82
+605.54%
-0.36
-111.02%
3.27
+168.60%
-4.77
Change In Payables And Accrued Expense
-1.47
-174.10%
1.98
+155.32%
-3.58
-312.02%
1.69
Change In Payable
-1.47
-174.10%
1.98
+155.32%
-3.58
-312.02%
1.69
Change In Account Payable
-1.47
-172.75%
2.02
+173.97%
-2.73
-441.43%
0.80
Change In Other Working Capital
-0.30
+48.55%
-0.58
-0.34%
-0.58
+59.20%
-1.43
Change In Other Current Assets
-0.16
+64.88%
-0.47
+13.52%
-0.54
-283.67%
0.29
Change In Other Current Liabilities
-0.24
-33.70%
-0.18
+9.95%
-0.20
-1.01%
-0.20
Investing Cash Flow
-0.20
+28.99%
-0.28
-47.59%
-0.19
-101.26%
14.84
Cash Flow From Continuing Investing Activities
-0.20
+28.99%
-0.28
-47.59%
-0.19
-101.26%
14.84
Net PPE Purchase And Sale
-0.20
+28.99%
-0.28
-20.52%
-0.23
-44.03%
-0.16
Purchase Of PPE
-0.20
+28.99%
-0.28
-20.52%
-0.23
-44.03%
-0.16
Sale Of PPE
—
—
—
—
Capital Expenditure
-0.20
+28.99%
-0.28
-20.52%
-0.23
-44.03%
-0.16
Net Investment Purchase And Sale
—
—
—
—
Sale Of Investment
—
—
—
—
Net Other Investing Changes
—
—
0.04
-99.72%
15.00
Financing Cash Flow
-0.30
-2133.33%
0.01
+137.50%
-0.04
+98.35%
-2.43
Cash Flow From Continuing Financing Activities
-0.30
-2133.33%
0.01
+137.50%
-0.04
+98.35%
-2.43
Net Issuance Payments Of Debt
—
—
0.00
+100.00%
-0.05
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
0.00
+100.00%
-0.05
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
0.00
+100.00%
-0.05
Net Long Term Debt Issuance
—
—
0.00
+100.00%
-0.05
Short Term Debt Payments
—
—
—
-0.05
Net Short Term Debt Issuance
—
—
—
-0.05
Net Common Stock Issuance
-0.30
0.00
+100.00%
-0.03
+99.10%
-3.00
Common Stock Payments
-0.30
0.00
+100.00%
-0.03
+99.10%
-3.00
Repurchase Of Capital Stock
-0.30
0.00
+100.00%
-0.03
+99.10%
-3.00
Proceeds From Stock Option Exercised
0.00
-100.00%
0.07
+45.65%
0.05
-93.71%
0.73
Net Other Financing Charges
-0.01
+90.38%
-0.05
+11.86%
-0.06
+45.87%
-0.11
Changes In Cash
0.03
+102.47%
-1.09
+53.96%
-2.37
-121.56%
11.00
Beginning Cash Position
22.06
-4.72%
23.15
-9.29%
25.52
+75.77%
14.52
End Cash Position
22.08
+0.12%
22.06
-4.72%
23.15
-9.29%
25.52
Free Cash Flow
0.33
+129.99%
-1.11
+53.37%
-2.37
-51.11%
-1.57
Interest Paid Supplemental Data
0.00
0.00
0.00
-100.00%
0.00
Income Tax Paid Supplemental Data
0.98
-62.04%
2.58
+79.31%
1.44
-68.49%
4.57
Change In Income Tax Payable
0.00
+100.00%
-0.04
+95.66%
-0.85
-195.84%
0.89
Change In Tax Payable
0.00
+100.00%
-0.04
+95.66%
-0.85
-195.84%
0.89
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category